Join the Albuterol group to help and get support from people like you.
Albuterol News
Tools You Can Use to Control Winter Asthma, Allergy Symptoms
WEDNESDAY, Dec. 18, 2024 – Winter is here, and that can make it difficult for those with asthma to control their symptoms. The cold air that comes with cooler temperatures can contribute to asthma...
ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma
TUESDAY, Oct. 29, 2024 – For patients with asthma, inhaled corticosteroids (ICS) combined with short-acting β agonists (SABA) and ICS combined with the long-acting β agonist formoterol are each a...
ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
FRIDAY, Oct. 25, 2024 – Many anaphylaxis protocols are incomplete and/or outdated, and there is a need for patient education regarding treatment of anaphylaxis, according to two studies presented at...
FDA Medwatch Alert: Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect
Mumbai, India July 6, 2023/ New Jersey, USA July 6, 2023 – Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US i...
FDA Medwatch Alert: FDA Alerts of Perrigo's Voluntary Albuterol Inhaler Recall
September 21, 2020 – The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of all unexpired albuterol sulfate inhalation aerosol manufactured...
FDA Approves ProAir Digihaler (albuterol sulfate) as the First and Only Digital Inhaler with Built-In Sensors
JERUSALEM--(BUSINESS WIRE)--Dec 21, 2018--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir ® Digihaler™ (a...
Teva Announces FDA Approval of ProAir RespiClick (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11
JERUSALEM--(BUSINESS WIRE)--Apr. 29, 2016-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick...
Teva Announces FDA Approval of ProAir RespiClick
JERUSALEM--(BUSINESS WIRE)--Apr. 1, 2015-- Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol...
FDA Medwatch Alert: Albuterol Sulfate Inhalation Solution, 0.083 percent (Nephron Pharmaceuticals): Recall - Aseptic Processing Simulation Results
ISSUE: Nephron Pharmaceuticals initiated a voluntary recall, at the retail level, of ten lots of product due to results from an internal monitoring process. NPC performs aseptic process simulation...
Further information
Related condition support groups
Asthma - Acute, Asthma - Maintenance, Asthma, Chronic Obstructive Pulmonary Disease